6 voices in 10 minutes: Strategies for diabetes reappearance prevention after remission
DOI:
https://doi.org/10.47196/diab.v54i3Sup.274Keywords:
diabetes, therapeutic approachAbstract
6 voices in 10 minutes: Strategies for weight loss in people with type 2 diabetes mellitus
Strategies for diabetes reappearance prevention after remission
After bariatric surgery, many patients still suffer from diabetes or fail to maintain remission. Generally, weight regain coincides with the latter.
Regarding this, GRAVITAS trial showed liraglutide 1.8% effectiveness and safeness for treatment of patients with persistent or recurrent diabetes after bariatric surgery. It is a placebo-controlled, randomised and double-blind trial that enrolled adults from five hospitals located in London. They had RYGB or gastric sleeve antecedents and had persistent or recurrent type 2 diabetes as well as HbA1c levels above 6.5% at least a year after bariatric surgery. This trial showed in liraglutide 1.8 mg/day-treated patients a drop in glycosylated hemoglobin of 1.22% or 13.3 mmol/mol (95%CI: -19,7 to -7 with p=0.0001).
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
